Variant report

Variant	nsv962538
Chromosome Location	chr20:1702183-1716952
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:310)
CpG islands
(count:428)
Chromatin interactive
region (count:4)
LncRNA
region (count:5)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:310 , 50 per page) page: 1 2 3 4 5 6 7

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr20:1702796-1703222	GM12878	blood:	n/a	n/a
2	ATF2	chr20:1714916-1715539	GM12878	blood:	n/a	n/a
3	ATF2	chr20:1702740-1703371	GM12878	blood:	n/a	n/a
4	ATF2	chr20:1712429-1712884	GM12878	blood:	n/a	n/a
5	BATF	chr20:1712545-1712765	GM12878	blood:	n/a	n/a
6	BATF	chr20:1712492-1712872	GM12878	blood:	n/a	n/a
7	BATF	chr20:1702831-1703291	GM12878	blood:	n/a	n/a
8	BATF	chr20:1715118-1715429	GM12878	blood:	n/a	n/a
9	BCL11A	chr20:1702831-1703251	GM12878	blood:	n/a	n/a
10	BCLAF1	chr20:1712466-1712861	GM12878	blood:	n/a	n/a
11	BCLAF1	chr20:1702414-1703353	GM12878	blood:	n/a	n/a
12	BCLAF1	chr20:1714937-1715553	GM12878	blood:	n/a	n/a
13	CEBPB	chr20:1711524-1711666	HepG2	liver:	n/a	chr20:1711629-1711640
14	CEBPB	chr20:1702615-1703194	H1-hESC	embryonic stem cell:	n/a	chr20:1702735-1702746
15	CEBPB	chr20:1702968-1703196	GM12878	blood:	n/a	n/a
16	CEBPB	chr20:1702720-1702758	HepG2	liver:	n/a	chr20:1702735-1702746
17	CEBPB	chr20:1702370-1703441	GM12878	blood:	n/a	chr20:1702735-1702746
18	CEBPB	chr20:1714709-1715576	GM12878	blood:	n/a	n/a
19	CHD1	chr20:1702745-1702984	GM12878	blood:	n/a	n/a
20	CHD2	chr20:1712605-1712817	GM12878	blood:	n/a	n/a
21	CREB1	chr20:1702727-1703328	H1-hESC	embryonic stem cell:	n/a	n/a
22	CTBP2	chr20:1702712-1703349	H1-hESC	embryonic stem cell:	n/a	n/a
23	CTCF	chr20:1715282-1715456	A549	lung:	n/a	n/a
24	CTCF	chr20:1715240-1715390	GM12866	blood:	n/a	n/a
25	CTCF	chr20:1702463-1702522	GM12891	blood:	n/a	n/a
26	CTCF	chr20:1715274-1715455	GM10266	blood:	n/a	n/a
27	CTCF	chr20:1715257-1715471	GM12892	blood:	n/a	n/a
28	CTCF	chr20:1715340-1715490	AG10803	skin:	n/a	n/a
29	CTCF	chr20:1715300-1715450	AG09309	skin:	n/a	n/a
30	CTCF	chr20:1715300-1715450	GM12872	blood:	n/a	n/a
31	CTCF	chr20:1715315-1715415	MCF-7	breast:	n/a	n/a
32	CTCF	chr20:1715320-1715470	GM12873	blood:	n/a	n/a
33	CTCF	chr20:1715300-1715450	HL-60	blood:	n/a	n/a
34	CTCF	chr20:1715300-1715450	AoAF	blood vessel:	n/a	n/a
35	CTCF	chr20:1715610-1715682	GM19240	blood:	n/a	n/a
36	CTCF	chr20:1715280-1715430	HBMEC	blood vessel:	n/a	n/a
37	CTCF	chr20:1715320-1715398	GM12891	blood:	n/a	n/a
38	CTCF	chr20:1715280-1715430	HRE	kidney:	n/a	n/a
39	CTCF	chr20:1715320-1715470	GM12878	blood:	n/a	n/a
40	CTCF	chr20:1715259-1715464	Fibrobl	skin:	n/a	n/a
41	CTCF	chr20:1715313-1715440	GM13976	blood:	n/a	n/a
42	CTCF	chr20:1715342-1715397	MCF-7	breast:	n/a	n/a
43	CTCF	chr20:1715300-1715450	MCF-7	breast:	n/a	n/a
44	CTCF	chr20:1715296-1715438	Pancreas_OC	pancreas:	n/a	n/a
45	CTCF	chr20:1715300-1715450	RPTEC	kidney:	n/a	n/a
46	CTCF	chr20:1715238-1715481	Gliobla	brain:	n/a	n/a
47	CTCF	chr20:1715320-1715470	GM12865	blood:	n/a	n/a
48	CTCF	chr20:1715220-1715370	HAc	cerebellar:	n/a	n/a
49	CTCF	chr20:1715220-1715370	GM12878	blood:	n/a	n/a
50	CTCF	chr20:1715300-1715450	SAEC	small airway:	n/a	n/a

(count:428 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr20:1716270-1716320	AG04449	skin:	fetal
2	chr20:1716270-1716320	AG04449	skin:	fetal
3	chr20:1716331-1716381	HEEpiC	esophagus:	n/a
4	chr20:1715296-1715346	HNPCEpiC	eye:	n/a
5	chr20:1715296-1715346	AG04449	skin:	fetal
6	chr20:1716510-1716560	PANC-1	pancreas:	n/a
7	chr20:1715296-1715346	HRCEpiC	kidney:	n/a
8	chr20:1715296-1715346	SK-N-SH	brain:	n/a
9	chr20:1715296-1715346	PANC-1	pancreas:	n/a
10	chr20:1712153-1712203	HCPEpiC	choroid plexus:	n/a
11	chr20:1716510-1716560	SK-N-MC	brain:	n/a
12	chr20:1716632-1716682	AG09309	skin:	n/a
13	chr20:1716632-1716682	U87	brain:	n/a
14	chr20:1716331-1716381	U87	brain:	n/a
15	chr20:1712153-1712203	ECC-1	luminal epithelium:	n/a
16	chr20:1712153-1712203	HPAEpiC	pulmonary alveolar:	n/a
17	chr20:1712396-1712446	Caco-2	colon:	n/a
18	chr20:1716510-1716560	HMEC	breast:	n/a
19	chr20:1716510-1716560	HNPCEpiC	eye:	n/a
20	chr20:1716331-1716381	AG09319	gingival:	n/a
21	chr20:1716632-1716682	NH-A	brain:	n/a
22	chr20:1716632-1716682	HCT-116	colon:	n/a
23	chr20:1716632-1716682	HCF	heart:	n/a
24	chr20:1716270-1716320	PANC-1	pancreas:	n/a
25	chr20:1716331-1716381	SKMC	muscle:	n/a
26	chr20:1716510-1716560	Hepatocyte	liver:	n/a
27	chr20:1712396-1712446	BJ	skin:	n/a
28	chr20:1715296-1715346	AG09309	skin:	n/a
29	chr20:1716632-1716682	HNPCEpiC	eye:	n/a
30	chr20:1715296-1715346	PFSK-1	brain:	n/a
31	chr20:1715296-1715346	NHDF-neo	bronchial:	n/a
32	chr20:1716270-1716320	Caco-2	colon:	n/a
33	chr20:1715296-1715346	MCF-7	breast:	n/a
34	chr20:1716632-1716682	NB4	blood:	n/a
35	chr20:1716632-1716682	HRCEpiC	kidney:	n/a
36	chr20:1712153-1712203	HRE	kidney:	n/a
37	chr20:1716632-1716682	H1-hESC	embryonic stem cell:	embryo
38	chr20:1712153-1712203	AG09319	gingival:	n/a
39	chr20:1712153-1712203	HepG2	liver:	n/a
40	chr20:1716510-1716560	K562	blood:	n/a
41	chr20:1716270-1716320	HIPEpiC	eye:	n/a
42	chr20:1716331-1716381	AoSMC	blood vessel:	n/a
43	chr20:1716331-1716381	SK-N-SH	brain:	n/a
44	chr20:1712396-1712446	AG09309	skin:	n/a
45	chr20:1716331-1716381	SK-N-MC	brain:	n/a
46	chr20:1716510-1716560	HepG2	liver:	n/a
47	chr20:1716270-1716320	CMK	blood:	n/a
48	chr20:1716270-1716320	SKMC	muscle:	n/a
49	chr20:1716270-1716320	SK-N-SH_RA	brain:	n/a
50	chr20:1712396-1712446	SK-N-SH_RA	brain:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr20:1513747..1514348-chr20:1714921..1715422,2	MCF-7	breast:
2	chr20:1489470..1490474-chr20:1714544..1715733,6	MCF-7	breast:
3	chr20:1484052..1484617-chr20:1714858..1715446,2	MCF-7	breast:
4	chr20:1715128..1715763-chr21:19211991..19212492,2	MCF-7	breast:

(count:5 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SIRPG-5	chr20:1716454-1716754	l_2058_chr20:1716453-1746293_testes
2	lnc-SIRPG-4	chr20:1702011-1702188	NONHSAT078128
3	lnc-SIRPG-4	chr20:1707166-1707494	NONHSAT078128
4	lnc-SIRPG-4	chr20:1708308-1708392	NONHSAT078128
5	lnc-SIRPG-4	chr20:1703157-1703311	NONHSAT078128

No data

Variant related genes	Relation type
ENSG00000234282	TF binding region
ENSG00000234282	CpG island

Extended variants
information (count: 658 )
Associated
traits (count: 62 )

Variant overlapped rSNPs/rCNVs (count:658 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs565066238	chr20:1702208-1702209	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs573997983	chr20:1702214-1702215	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs532397456	chr20:1702238-1702239	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs11906144	chr20:1702240-1702241	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs141312284	chr20:1702245-1702246	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs397748749	chr20:1702251-1702252	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs566002781	chr20:1702292-1702293	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs374509075	chr20:1702304-1702305	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs192905992	chr20:1702371-1702372	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs140127775	chr20:1702380-1702381	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs11906175	chr20:1702419-1702420	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs537108505	chr20:1702428-1702429	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs558671696	chr20:1702447-1702448	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs80297567	chr20:1702459-1702460	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs534921727	chr20:1702503-1702504	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs553305829	chr20:1702533-1702534	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs575045771	chr20:1702562-1702563	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs150294888	chr20:1702577-1702578	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs138353406	chr20:1702578-1702579	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs184129849	chr20:1702579-1702580	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs188081461	chr20:1702617-1702618	Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs11904920	chr20:1702655-1702656	Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs143066100	chr20:1702685-1702686	Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs111239071	chr20:1702714-1702715	Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs191386851	chr20:1702730-1702731	Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs529955154	chr20:1702791-1702792	Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs202510	chr20:1702792-1702793	Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs561711467	chr20:1702835-1702836	Enhancers Bivalent Enhancer Active TSS Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs544867508	chr20:1702859-1702860	Enhancers Bivalent Enhancer Active TSS Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs530839139	chr20:1702874-1702875	Enhancers Bivalent Enhancer Active TSS Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs552235103	chr20:1702911-1702912	Enhancers Bivalent Enhancer Active TSS Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs78762974	chr20:1702923-1702924	Enhancers Bivalent Enhancer Active TSS Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs565413183	chr20:1702931-1702932	Enhancers Bivalent Enhancer Active TSS Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs575314011	chr20:1702933-1702934	Enhancers Bivalent Enhancer Active TSS Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs570574469	chr20:1702946-1702947	Enhancers Bivalent Enhancer Active TSS Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs61306473	chr20:1702950-1702951	Enhancers Bivalent Enhancer Active TSS Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs146142469	chr20:1702953-1702954	Enhancers Bivalent Enhancer Active TSS Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs568568849	chr20:1703034-1703035	Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs3818167	chr20:1703071-1703072	Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs202511	chr20:1703106-1703107	Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs530339051	chr20:1703114-1703115	Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs6111165	chr20:1703124-1703125	Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs202512	chr20:1703134-1703135	Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs537078047	chr20:1703154-1703155	Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs77636242	chr20:1703163-1703164	Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
46	rs138973797	chr20:1703179-1703180	Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
47	rs202513	chr20:1703187-1703188	Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	TF binding region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs540774573	chr20:1703220-1703221	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
49	rs183686781	chr20:1703266-1703267	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
50	rs142120143	chr20:1703389-1703390	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:62)

Disease	PMID	Source
Hodgkin''s lymphoma	18641027	CNVD
Myelofibrosis	22110671	CNVD
Intellectual disability	22045946	CNVD
Glioblastoma multiforme	22286061	CNVD
Hepatocellular carcinoma	22174799	CNVD
Colorectal cancer	19455253	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	17603634	CNVD
Colorectal cancer	19359472	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Intracranial aneurysm	16715129	CNVD
Colorectal cancer	16774939	CNVD
Autism	18414403	CNVD
Neurocytoma	17123091	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16397240	CNVD
abortions and stillbirths	19751515	CNVD
Wilms tumour	21544195	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	16272173	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	19627613	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Central neurocytomas	17123091	CNVD
Colorectal cancer	16272173	CNVD
Gastric cancer	17908304	CNVD
Urothelial carcinoma	21177765	CNVD
lymphocytic leukemia	21291569	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Ewing''s sarcoma	17952124	CNVD
Oral cancer	21386901	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Colorectal cancer	21645411	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	17363583	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Lung cancer	18438408	CNVD

Chromatin state (count:182 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr20:1698600-1703400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
2	chr20:1698600-1703400	Enhancers	NHEK	skin
3	chr20:1698600-1703600	Enhancers	HMEC	breast
4	chr20:1699800-1703200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
5	chr20:1700200-1702600	Weak transcription	Brain Anterior Caudate	brain
6	chr20:1700200-1703400	Enhancers	Primary B cells from peripheral blood	blood
7	chr20:1700600-1703000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
8	chr20:1700800-1702200	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
9	chr20:1701000-1702600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
10	chr20:1701400-1703600	Enhancers	Primary B cells from cord blood	blood
11	chr20:1701400-1714600	Weak transcription	Brain Hippocampus Middle	brain
12	chr20:1701600-1702400	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
13	chr20:1701600-1702400	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
14	chr20:1701600-1702400	Enhancers	GM12878-XiMat	blood
15	chr20:1701800-1702600	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
16	chr20:1701800-1702800	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
17	chr20:1701800-1702800	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
18	chr20:1701800-1703200	Enhancers	Monocytes-CD14+_RO01746	blood
19	chr20:1701800-1703800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
20	chr20:1701800-1703800	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
21	chr20:1701800-1703800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
22	chr20:1701800-1704000	Enhancers	ES-I3 Cell Line	embryonic stem cell
23	chr20:1701800-1704000	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
24	chr20:1702000-1702600	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
25	chr20:1702000-1702800	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
26	chr20:1702200-1702600	Enhancers	HUES6 Cell Line	embryonic stem cell
27	chr20:1702200-1703200	Enhancers	Primary monocytes fromperipheralblood	blood
28	chr20:1702400-1702600	Enhancers	iPS-15b Cell Line	embryonic stem cell
29	chr20:1702400-1703200	Enhancers	H9 Cell Line	embryonic stem cell
30	chr20:1702400-1703600	Flanking Active TSS	GM12878-XiMat	blood
31	chr20:1702600-1702800	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
32	chr20:1702600-1702800	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
33	chr20:1702600-1702800	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
34	chr20:1702600-1702800	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
35	chr20:1702600-1702800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
36	chr20:1702600-1703000	Enhancers	Primary T cells from cord blood	blood
37	chr20:1702600-1703000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
38	chr20:1702600-1703000	Strong transcription	Brain Anterior Caudate	brain
39	chr20:1702600-1707000	Weak transcription	Primary neutrophils fromperipheralblood	blood
40	chr20:1702800-1703200	Active TSS	HUES48 Cell Line	embryonic stem cell
41	chr20:1702800-1703200	Enhancers	HUES64 Cell Line	embryonic stem cell
42	chr20:1702800-1703200	Enhancers	iPS-15b Cell Line	embryonic stem cell
43	chr20:1702800-1703200	Enhancers	Primary T helper naive cells fromperipheralblood	blood
44	chr20:1702800-1703400	Active TSS	HUES6 Cell Line	embryonic stem cell
45	chr20:1702800-1703400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
46	chr20:1702800-1703400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
47	chr20:1703000-1704000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
48	chr20:1703000-1704600	Weak transcription	Brain Anterior Caudate	brain
49	chr20:1703200-1703400	Flanking Active TSS	H9 Cell Line	embryonic stem cell
50	chr20:1703200-1703400	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links